Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Microsoft (MSFT.US) faces a "higher bar" after its rebound! Morgan Stanley remains bullish: Azure growth and Copilot commercialization are key drivers, target price set at $600

Microsoft (MSFT.US) faces a "higher bar" after its rebound! Morgan Stanley remains bullish: Azure growth and Copilot commercialization are key drivers, target price set at $600

智通财经智通财经2026/10/20 03:52
Show original

Morgan Stanley stated that Microsoft's stock price has recently rebounded, so the tech giant will face a "higher hurdle" if it wants to maintain its upward momentum.

According to Jinse Finance, Morgan Stanley stated that Microsoft (MSFT.US) shares have recently rebounded, so the tech giant will face a “higher bar” to maintain its upward momentum. The bank has given Microsoft an “Overweight” rating and set a target price of $600, which represents an upside of nearly 12% compared to Microsoft’s closing price of $533.52 on Monday.

Morgan Stanley believes that Microsoft needs to demonstrate Azure’s growth can remain in the mid-40% range, further promote the commercialization of Microsoft 365 and Copilot, and maintain “strict discipline” in operating expense control to extend this growth trend into its fiscal year 2027.

Morgan Stanley analyst Adam Wood further pointed out that demand for Azure remains “robust” in both core cloud business and Artificial Intelligence (AI) workloads. The bank’s recent Chief Information Officer (CIO) survey found that, as workloads migrate to the cloud, Microsoft continues to be the biggest beneficiary of IT budget share growth, ahead of Amazon (AMZN.US) and others.

The analysts wrote: “Importantly, we believe that increased data center capacity availability will provide additional support for Azure growth. According to our latest capacity tracking data, Microsoft is expected to add about 3.25GW of new capacity online in fiscal year 2026, and we project about 4.25GW of capacity will come online in fiscal 2027. As these capacities ramp up and the overall capacity system continues to improve in efficiency, we believe higher capacity availability will be another key lever driving Azure’s growth.”

As for Microsoft 365, recent surveys of partners show that the E3 to E5 upgrade trend remains strong, largely due to security needs, while early adoption of E7 is another potential upside driver. The analysts added that, meanwhile, Copilot adoption rates are also improving.

In a note to clients, the analysts wrote: “Following last quarter’s better-than-expected results and initial guidance for fiscal 2027 showing durable growth momentum in core businesses, street narrative around Microsoft has materially improved.”

The analysts added: “With continued improvements in both market narrative and fundamentals, Microsoft’s valuation has risen over the past several months, which means market expectations for the company are now higher heading into the first quarter of fiscal 2027 (F1Q27) results. However, Microsoft’s current share price is trading at about 27 times next twelve months (NTM) GAAP earnings per share, which is still below the historical average of around 28 to 29 times. On a growth-adjusted basis, this discount is even more notable—Microsoft’s current NTM P/E/G ratio is about 1.25 times, compared to a historical range of about 1.9 to 2.2 times. Given the market expects Microsoft’s earnings growth rate will exceed 20% after fiscal 2027, we continue to find the risk-reward attractive, although we acknowledge that higher valuation and improved market sentiment mean there is now a higher bar for further share price upside ahead of the F1Q earnings report.”

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

智通财经•2026/10/26 04:20
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks

Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.

智通财经•2026/10/26 03:41
Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks

Trump promotes the "manufacturing card" again for midterm elections: Audi to invest $4 billion in a U.S. plant, plans annual production of 200,000 SUVs

Audi plans to invest 4 billion dollars to build a factory in the United States, with an annual production capacity of 200,000 SUVs, creating 4,500 jobs. The German labor union criticized the CEO's supportive attitude as "puzzling," and the final decision will be made by the Volkswagen supervisory board.

智通财经•2026/10/26 03:11
Trump promotes the "manufacturing card" again for midterm elections: Audi to invest $4 billion in a U.S. plant, plans annual production of 200,000 SUVs